Ballard Spahr represented Array BioPharma Inc. (Nasdaq: ARRY), in the recent closing of a public offering by the biopharmaceutical company, which generated total gross proceeds of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now